source
- FDA approves adjuvant atezolizumab for MRD-positive muscle-invasive bladder cancerThe U.S. Food and Drug Administration has granted approval for adjuvant atezolizumab in patients with muscle‑invasive bladder cancer who test positive for circulating tumor DNA, indicating molecula…
- FDA places clinical hold on Aardvark’s Prader-Willi drug amid heart safety concernsThe Food and Drug Administration has issued a clinical hold on Aardvark Therapeutics' experimental treatment ARD-101 for Prader-Willi Syndrome after safety signals were identified. The hold follow…